Novo Nordisk sets 2030 ambitions, targets >DKK150B pipeline sales by 2035
hapabapa
Despite unveiling 2030 growth goals and a $23B obesity sales target, Novo Nordisk (NVO) saw its shares slide as much as 7% following its Capital Markets Day presentation in London on Monday.
The Wegovy-maker targets launching more than five multi-blockbusters
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.